FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A ...
Luca Antonelli, MD; Davide Ardizzone, MD; Isamu Tachibana, MD; Nabil Adra, MD; Clint Cary, MD; Lee Hugar, MD; Wade J. Sexton, MD; Aditya Bagrodia, MD; Michal Mego, MD ...
RIYADH, Saudia Arabia, Dec. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has achieved a groundbreaking medical milestone in the Middle East by ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
In the AXSANA/EUBREAST 3(R) study, researchers compared data about recurrence outcomes of more-invasive and less-invasive lymph node procedures.
Researchers found that adding retroperitoneal lymphadenectomy to cytoreductive surgery did not improve survival among patients with advanced ovarian cancer. The addition of retroperitoneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback